Activation of cGAS confers PARP inhibitor resistance in ovarian cancer via the TBK1-IRF3 axis.
Guo H, Lu R, Yuan S, Xu F, Huang C, Li J, Ge W, Geng Y, Zhang Y, Liu Q, Wang P, Li W.
Guo H, et al. Among authors: li w.
Int J Clin Exp Pathol. 2024 Nov 15;17(11):429-438. doi: 10.62347/XOPN6908. eCollection 2024.
Int J Clin Exp Pathol. 2024.
PMID: 39660334
Free PMC article.